BTIG analyst Mark Massaro raised the firm’s price target on Natera (NTRA) to $230 from $210 and keeps a Buy rating on the shares. The company delivered a record increase in Signatera MRD volumes to the tune of 21.5k q/q in Q3, representing 54% y/y growth, the analyst tells investors in a research note. Signatera demand is robust, and there is also good upside on average selling prices, the firm added.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTRA:
- Natera price target raised to $250 from $200 at Canaccord
- Natera price target raised to $230 from $210 at Barclays
- Natera’s Strong Q3 Performance and Growth Outlook Drive Buy Rating
- Natera Inc. Reports Strong Revenue Growth in Q3 2025
- Closing Bell Movers: Expedia up 15%, Affirm up 12% on earnings beats